Trafalgar International (GCAN) Long-Term Debt Issuances (2017 - 2026)
Trafalgar International (GCAN) posted Long-Term Debt Issuances of $5000.0 for Q1 2026, down 98.0% on a QoQ basis from $250000.0 in Q2 2021.
Analysis
Trafalgar International (GCAN) Long-Term Debt Issuances (2017 - 2026) Analysis & Trends
Trafalgar International has reported Long-Term Debt Issuances for 6 years, with the latest figure at $5000.0 in Q1 2026.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $255000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3600.0, changed N/A from the prior year.
- Long-Term Debt Issuances was $5000.0 for Q1 2026 at Trafalgar International, down from $250000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $5000.0 in Q1 2026, with the low at $5000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 1.98 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 4.88 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | -3,000.00 |
| Jun 30, 2020 | 83,001.00 |
| Mar 31, 2020 | 426,667.00 |
| Mar 31, 2019 | 250,000.00 |
| Sep 30, 2018 | -20,000.00 |
| Jun 30, 2018 | 111,127.00 |
| Mar 31, 2018 | 783.00 |
| Jun 30, 2017 | 7,443.00 |
| Mar 31, 2017 | 4,557.00 |